Author:
Rodriguez-Mateos Pablo,Ngamsom Bongkot,Ameyo Daglus,Wakaba Patrick,Shiluli Clement,Iles Alexander,Gitaka Jesse,Pamme Nicole
Abstract
AbstractGonorrhea is the second most common sexually transmitted infection (STI) with around 87 million cases worldwide estimated in 2016 by the World Health Organization. With over half of the cases being asymptomatic, potential life-threatening complications and increasing numbers of drug-resistant strains, routine monitoring of prevalence and incidence of infections are key preventive measures. Whilst gold standard qPCR tests have excellent accuracy, they are neither affordable nor accessible in low-resource settings. In this study, we developed a lab-on-a-chip platform based on microscale immiscible filtration to extract, concentrate and purify Neisseria gonorrhoeae DNA with an integrated detection assay based on colorimetric isothermal amplification. The platform was capable of detecting as low as 500 copies/mL from spiked synthetic urine and showed no cross-reactivity when challenged with DNAs from other common STIs. The credit card–size device allows DNA extraction and purification without power or centrifuges, and the detection reaction only needs a low-tech block heater, providing a straightforward and visual positive/negative result within 1 h. These advantages offer great potential for accurate, affordable and accessible monitoring of gonorrhea infection in resource-poor settings.
Funder
Global Challenges Research Fund
Stockholms Universitet
Stockholm University
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference43 articles.
1. Kirkcaldy RD, Weston E, Segurado AC, Hughes G. Epidemiology of gonorrhoea: a global perspective. Sex Health. 2019;16(5):401–11. https://doi.org/10.1071/SH19061.
2. Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N. Taylor MM (2019) Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates. Bull World Health Organ. 2016;97(8):548-562P. https://doi.org/10.2471/BLT.18.228486.
3. Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC. Kent CK (2013) The estimated direct medical cost of selected sexually transmitted infections in the United States. Sex Transm Dis. 2008;40(3):197–201. https://doi.org/10.1097/OLQ.0b013e318285c6d2.
4. Centers for Disease Control and Prevention (2019) Sexually transmitted disease surveillance 2019. Division of STD Prevention
5. April 2021. https://www.cdc.gov/std/statistics/2019/std-surveillance-2019.pdf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献